Quarry LP’s Stoke Therapeutics STOK Stock Holding History

Quarry LP’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-956	Closed	-$22.5K	–	2594
2025 Q3	$22.5K	Buy	+956	New	+$16.4K	﹤0.01%	1330
2024 Q3	–	Sell	-118	Closed	-$1.59K	–	2062
2024 Q2	$1.59K	Buy	+118	New	+$1.59K	﹤0.01%	1659

Other funds holding STOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quarry LP's STOK Position: Q4 2025 in Review

Quarry LP sold out of Stoke Therapeutics (STOK) in Q4 2025, closing a stake of 956 shares — an estimated $22.5K sold.

Quarry LP first reported a position in STOK in Q2 2024 and held it in 2 quarters. The position peaked at $22.5K in Q3 2025. 183 funds tracked by Wall St. Rank hold STOK as of Q4 2025.

Quarry LP reported no remaining Stoke Therapeutics position as of Q4 2025 after selling out during the quarter.
Quarry LP sold 956 Stoke Therapeutics shares in Q4 2025, an estimated $22.5K.
Quarry LP first reported a position in Stoke Therapeutics in Q2 2024 and held it in 2 quarters.
Quarry LP's Stoke Therapeutics position peaked at $22.5K in Q3 2025.
183 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q4 2025.

Based on Quarry LP's 13F filing for Q4 2025, filed 13 Feb 2026.